Navigation Links
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2009
Date:4/29/2009

xis, commented, "While the impact of the weak economy took its toll during the quarter, we are pleased with the overall results for the year and we look forward to fiscal 2010. Given current economic conditions we are pleased with the solid double-digit (12 percent) annual growth in the recurring revenue component of our business, maintaining solid gross margins and selling more than 5 million reagent discs during the fiscal year, a milestone for the company. We are also gratified with the initial market acceptance of our recently introduced VetScan Canine Heartworm Rapid Tests."

"With regards to the financial condition of the company, Abaxis is in a very strong position with cash and investments approaching $75 million and a balance sheet with no long-term debt. Our dedication over the years to operating this company on a conservative financial basis has served us well in the past and particularly so during the current global macro-economic downturn. We believe that as the economy works its way through the recession, Abaxis is well positioned to resume a strong growth trajectory."

"An important contributor to that growth trajectory will be the process improvements and product manufacturing quality that have been achieved in the past 18 months across our entire manufacturing platform under the watchful eye of Don Wood, our vice president of operations. Don has reshaped our manufacturing processes and has focused the energy and innovative spirit of our team to achieve significant efficiencies in the production of leading-edge point-of-care technology. The Board of Directors have elected to promote Don Wood to the position of Chief Operations Officer, effective April 22, 2009, and he will be an integral part of the executive management team of Abaxis. We appreciate all of Don's efforts to this point and we expect even greater contributions going forward," concluded Mr. Severson.

Conference Call


'/>"/>

SOURCE Abaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Abaxis to Report Fourth Quarter Fiscal 2009 Financial Results Wednesday, April 29, 2009
2. ABAXIS Realigns North American Medical Sales and Marketing
3. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
4. Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum
5. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
6. ABAXIS Announces Launch of Two New Products at the NAVC
7. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
8. Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum
9. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
10. Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status
11. Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
(Date:5/4/2015)... METTLER TOLEDO has announced an upcoming ... in a GXP Regulated Laboratory ", featuring independent ... will be presented on May 27, 2015 at ... a critical component of pharmaceutical product quality and ... recent years an increasing number of inspections have ...
(Date:5/4/2015)... OK and Seattle, WA (PRWEB) May 04, 2015 ... the formation of a collaboration to facilitate development of ... of ophthalmic disorders that lead to blindness, including Diabetic ... the MiDROPS™ formulation platform developed by EyeCRO, which can ... eye via a topical eyedrop. , Under the ...
(Date:5/4/2015)... 04, 2015 CCL, a top-ranked, global ... unique program to other leadership development consultancies. “The ... CCL and successful practitioners, expanding our capacity to drive ... said John R. Ryan, CCL President and CEO. , ... CCL Partner Network , it will schedule a one-on-one ...
(Date:5/4/2015)... New West Medicare is excited to ... to manage outpatient advanced imaging services for its members. ... its members are provided the right test at the ... with New West Medicare’s physicians and hospitals, Care to ... advanced imaging and provide an objective basis for informed ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... LOS ANGELES, March 5 With the nation focused ... Valley) recently announced Assembly Bill 562 ( ... to businesses and consumers that have fallen victim to ... decreases health care premium costs. It requires insurance companies ...
... YORK, March 5 An article published in the ... , a joint publication of United Spinal Association ( ... Multiple Sclerosis (NARCOMS), reveals the importance of understanding ... it can also lead to a greater understanding and ...
... day for six months were able to increase the flaccid ... erectile function by up to 36%, according to an independent ... International . , Researchers from San Giovanni Battista Hospital at ... treatment could provide a viable alternative to surgery, as the ...
... Sick or injured African-American patients wait about an ... being transferred to an inpatient hospital bed following ... study published in the journal Academic Emergency ... the urgency to find equitable, cost-effective solutions to ...
... Already Breaking down Silos and Benefiting from Paperless ... Waters Corporation (NYSE: WAT ) ... strategic partnership to integrate laboratory software for improved ... Collaborating with existing common customers, Waters(R) and LabVantage(R) ...
... Texas and SAN FRANCISCO, March 5 Preferred ... payment and transaction-processing services for the health care ... ), the world,s largest retail payments network, today ... brand for PHT,s A-Claim(TM) medical payment solution for ...
Cached Medicine News:Health News:New Health Care Legislation Stops 'Opportunistic' Insurance Pricing 2Health News:United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults 2Health News:Penile extender increased flaccid length by almost a third says independent clinical study 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 3Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 2Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 3Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 4Health News:Preferred Health Technology and Visa Inc. Team Up on Comprehensive Point-of-Service Medical Payments Solution 2Health News:Preferred Health Technology and Visa Inc. Team Up on Comprehensive Point-of-Service Medical Payments Solution 3
(Date:5/4/2015)... 4, 2015 Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, animal health and ... quarter ended March 28, 2015. Net sales ... an increase of 1.4% compared with the first quarter ... currencies and a 6.0% decline related to foreign currency ...
(Date:5/4/2015)... MONMOUTH JUNCTION, N.J. , May 4, 2015 ... critical care immunotherapy company commercializing its CytoSorb® extracorporeal ... patients in multiple countries worldwide, will report Q1 ... Monday, May 11, 2015.  CytoSorbents, ... presentation webcast that will recount both operational and ...
(Date:5/4/2015)... Utah , May 4, 2015 ... a manufacturer and marketer of rehabilitation and physical ... into definitive agreements to raise approximately $4,000,000 in ... LLC and certain of its affiliates (together with ... focused on the healthcare industry. The financing will ...
Breaking Medicine Technology:Henry Schein Reports Record First Quarter Results 2Henry Schein Reports Record First Quarter Results 3Henry Schein Reports Record First Quarter Results 4Henry Schein Reports Record First Quarter Results 5Henry Schein Reports Record First Quarter Results 6Henry Schein Reports Record First Quarter Results 7Henry Schein Reports Record First Quarter Results 8Henry Schein Reports Record First Quarter Results 9Henry Schein Reports Record First Quarter Results 10Henry Schein Reports Record First Quarter Results 11Henry Schein Reports Record First Quarter Results 12Henry Schein Reports Record First Quarter Results 13Henry Schein Reports Record First Quarter Results 14Henry Schein Reports Record First Quarter Results 15Henry Schein Reports Record First Quarter Results 16Henry Schein Reports Record First Quarter Results 17CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4
... Demonstrates Impressive Single Agent Efficacy in Patients who Progressed ... or after Treatment with both a VEGF Receptor Inhibitor ... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... (perifosine), the Company,s Akt-inhibitor for cancer, as a treatment ...
... 29 Spirus Medical, Inc. ( www.spirusmed.com ... therapeutic advancement systems for gastroenterology, urology and gynecology, ... devices have performed complete examinations of the small ... Digestive Disease Week 2009 in Chicago, May 30 ...
Cached Medicine Technology:Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 2Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 3Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 4Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 5Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM) 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: